Director of Vaxcyte, Inc. (NASDAQ:PCVX), Hopfner Robert Lorne, sells 220,744 shares worth $6,223,692
According to Vaxcyte, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:22 PM, company Director, Hopfner Robert Lorne disclosed selling 220,744 shares at a cost of $28.19. At the time of this transaction (Feb 09), this trade was worth $6,223,692 in total. As of Feb 09, Hopfner Robert Lorne now owns 1,483,576 shares in total worth about $39,759,836.800000004.
For the last few recent trades made by Vaxcyte, Inc. (NASDAQ:PCVX) Director, Hopfner Robert Lorne, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 79,796 shares at the rate of $25.79 per share. Total worth of this trade was $2,058,117. Total number of shares owned as of Feb 08 were 1,704,320
- SEC Form 4 filing: Feb 10: Sold 78,158 shares at the rate of $26.53 per share. Total worth of this trade was $2,073,658. Total number of shares owned as of Feb 10 were 1,405,418
- SEC Form 4 filing: Feb 02: Sold 14,234 shares at the rate of $25.13 per share. Total worth of this trade was $357,700. Total number of shares owned as of Feb 02 were 1,786,884
Posted by
George Daniels
on Wednesday February 10 2021, 10:42 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
